News Industry News Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform July 15, 2019
News Industry News Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™ May 06, 2019
News Industry News FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation March 14, 2019
News Industry News Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc. January 24, 2018
News Industry News 4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum June 16, 2017
News Industry News Valcare Medical, an Accelmed Portfolio Company, Announces Successful First-In-Human Procedures of the Amend™ Catheter Delivered Annuloplasty Ring June 20, 2016
News Industry News NeoChord Receives FDA Approval to begin Clinical Trial for Treatment of Degenerative Mitral Valve Regurgitation May 16, 2016
News Industry News BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device March 07, 2016
News Industry News NaviGate Cardiac Structures Inc. (“NCSI”) Reports First Patient Treated for Mitral Regurgitation (“MR”) November 22, 2015
News Industry News Neovasc Tiara™ Featured in Live Case Session at TCT 2015 Scientific Symposium October 16, 2015
News Industry News MValve Technologies Implants First Human Catheter Based Mitral Valve Replacement System October 05, 2015
News Industry News Early Patient Cases with Mitra-Spacer™ System presented at PCR London Valves 2015 September 21, 2015
News Industry News Harpoon Medical Enrolls Ten Patients in Early Feasibility Study with 100% Procedural Success September 15, 2015
News Industry News Valtech's Cardioband® Receives CE Mark Approval for Mitral Valve Repair September 14, 2015
News Industry News Medtronic to Acquire Twelve, Inc., Developer of Transcatheter Mitral Valve Replacement Device August 25, 2015
News Industry News CardiAQ™ Valve Technologies reports first-in-human percutaneous transfemoral, transseptal implantation with its second generation transcatheter bioprosthetic mitral heart valve June 23, 2015